Resverlogix (RVX) Competitors C$0.10 +0.01 (+5.56%) As of 03:54 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock RVX vs. HBP, SCYB, COM, NVH, IGX, MDNA, PDP, COV, SVA, and EMHShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Helix BioPharma (HBP), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Medicenna Therapeutics (MDNA), Pediapharm (PDP), Covalon Technologies (COV), Sernova (SVA), and Emerald Health Therapeutics (EMH). These companies are all part of the "biotechnology" industry. Resverlogix vs. Its Competitors Helix BioPharma Scythian Biosciences 138267 (COM.TO) Novoheart IntelGenx Technologies Medicenna Therapeutics Pediapharm Covalon Technologies Sernova Emerald Health Therapeutics Helix BioPharma (TSE:HBP) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends and media sentiment. Is HBP or RVX more profitable? Helix BioPharma's return on equity of 1,803.57% beat Resverlogix's return on equity.Company Net Margins Return on Equity Return on Assets Helix BioPharmaN/A 1,803.57% -279.98% Resverlogix N/A 6.06%-34.90% Do institutionals and insiders hold more shares of HBP or RVX? 0.0% of Helix BioPharma shares are held by institutional investors. Comparatively, 0.0% of Resverlogix shares are held by institutional investors. 2.2% of Helix BioPharma shares are held by insiders. Comparatively, 42.7% of Resverlogix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, HBP or RVX? Helix BioPharma has a beta of -0.449843, suggesting that its stock price is 145% less volatile than the S&P 500. Comparatively, Resverlogix has a beta of 1.154049, suggesting that its stock price is 15% more volatile than the S&P 500. Does the media refer more to HBP or RVX? In the previous week, Helix BioPharma had 3 more articles in the media than Resverlogix. MarketBeat recorded 3 mentions for Helix BioPharma and 0 mentions for Resverlogix. Helix BioPharma's average media sentiment score of 0.24 beat Resverlogix's score of 0.00 indicating that Helix BioPharma is being referred to more favorably in the media. Company Overall Sentiment Helix BioPharma Neutral Resverlogix Neutral Which has preferable valuation & earnings, HBP or RVX? Resverlogix is trading at a lower price-to-earnings ratio than Helix BioPharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHelix BioPharmaN/AN/A-C$50.55M-C$1.03-1.48ResverlogixN/AN/A-C$2.81M-C$0.04-2.38 SummaryResverlogix beats Helix BioPharma on 6 of the 10 factors compared between the two stocks. Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RVX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$27.21MC$237.81MC$5.75BC$9.42BDividend Yield7.02%3.78%5.69%6.50%P/E Ratio-2.3841.2574.9325.95Price / SalesN/A4,870.38452.359.54Price / Cash132.5013.1925.8183.29Price / Book-0.41126.0413.255.61Net Income-C$2.81M-C$90.99MC$3.29BC$301.20M7 Day PerformanceN/A2.35%0.47%1.82%1 Month PerformanceN/A21.81%4.60%8.55%1 Year PerformanceN/A657.62%73.42%37.62% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.10+5.6%N/A+50.0%C$27.21MN/A-2.3819Gap UpHBPHelix BioPharmaN/AC$1.43+2.1%N/A+21.6%C$106.93MN/A-1.399SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423.50K-13.95N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpMDNAMedicenna TherapeuticsN/AC$1.04-1.9%N/A-49.0%C$86.75MN/A-6.5020Gap UpHigh Trading VolumePDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/ACOVCovalon TechnologiesN/AC$2.30+0.9%N/A-26.4%C$63.06MC$32.99M25.56N/ASVASernovaN/AC$0.18-2.8%C$2.00+1,042.9%-29.4%C$57.49MN/A-2.501,959Gap UpEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161 Related Companies and Tools Related Companies Helix BioPharma Competitors Scythian Biosciences Competitors 138267 (COM.TO) Competitors Novoheart Competitors IntelGenx Technologies Competitors Medicenna Therapeutics Competitors Pediapharm Competitors Covalon Technologies Competitors Sernova Competitors Emerald Health Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:RVX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
